Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMay 31, 2023EPINEPHrine added to dextrose 5%Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0701-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0700-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0699-2023Class IITerminatedMay 31, 2023Neonatal PN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0698-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0697-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0696-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0695-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0694-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0693-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0692-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0691-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0690-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0689-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0688-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0687-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0686-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0685-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0684-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0683-2023Class IITerminatedMay 31, 2023Neonatal TPN Starter BagLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0682-2023Class IITerminatedMay 31, 2023Modified del Nido MicroplegiaLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0681-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0680-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0679-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0678-2023Class IITerminatedMay 31, 2023Microplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0677-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0676-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0675-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0674-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0673-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0672-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0671-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0670-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0669-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0668-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0667-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0666-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0665-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0664-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0663-2023Class IITerminatedMay 31, 2023Cardioplegia SolutionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0662-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.